Typhoid Fever in the Eastern Mediterranean Region: A Systematic Review, 1990–2021

dc.contributor.authorAppiah, Grace D.
dc.contributor.authorLe, Phong
dc.contributor.authorPrentice-Mott, Graeme
dc.contributor.authorBias, Megan
dc.contributor.authorPratt, Caroline Quinn
dc.contributor.authorMatar, Ghassan
dc.contributor.authorPindyck, Talia N.
dc.contributor.authorAbou Fayad, Antoine G.
dc.contributor.authorKim, Sunkyung
dc.contributor.authorMintz, Eric Daniel
dc.contributor.departmentExperimental Pathology, Microbiology, and Immunology
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:39:13Z
dc.date.available2025-01-24T11:39:13Z
dc.date.issued2023
dc.description.abstractThe occurrence and antimicrobial resistance (AMR) of typhoid fever in the WHO Eastern Mediterranean Region (EMR) are poorly characterized. Robust surveillance data are needed to inform strategies for typhoid control and prevention in the region. We conducted a systematic review of typhoid fever occurrence, complications, and AMR patterns in EMR countries. We identified 70 studies published from 1990 to 2021, including a total of 44,541 cases with blood culture confirmed typhoid fever in 12 EMR countries, with 48 (69%) studies and 42,008 cases from Pakistan. Among 56 studies with AMR data, fluroquinolone (68% of 13,013 tested isolates), and multidrug resistance (40% of 15,765 tested isolates) were common. Forty (57%) of the 56 studies were from Pakistan, and all reports of extensively drug resistant Salmonella Typhi (48% of 9,578 tested isolates) were from studies in Pakistan. Our findings support the need for continued efforts to strengthen surveillance and laboratory capacity for blood-culture detection of typhoid fever in the region, including data from an ongoing collaboration among CDC, the American University of Beirut, and the WHO EMR office. Copyright © 2023 The American Society of Tropical Medicine and Hygiene.
dc.identifier.doihttps://doi.org/10.4269/ajtmh.22-0075
dc.identifier.eid2-s2.0-85147317471
dc.identifier.pmid36538895
dc.identifier.urihttp://hdl.handle.net/10938/29212
dc.language.isoen
dc.publisherAmerican Society of Tropical Medicine and Hygiene
dc.relation.ispartofAmerican Journal of Tropical Medicine and Hygiene
dc.sourceScopus
dc.subjectAnti-bacterial agents
dc.subjectHumans
dc.subjectLaboratories
dc.subjectPakistan
dc.subjectSalmonella typhi
dc.subjectTyphoid fever
dc.subjectAntiinfective agent
dc.subjectAntibiotic resistance
dc.subjectArticle
dc.subjectBacterium isolate
dc.subjectBlood culture
dc.subjectDisease control
dc.subjectDisease surveillance
dc.subjectEastern europe
dc.subjectHuman
dc.subjectMultidrug resistance
dc.subjectSalmonella enterica serovar typhi
dc.subjectSystematic review
dc.subjectLaboratory
dc.titleTyphoid Fever in the Eastern Mediterranean Region: A Systematic Review, 1990–2021
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2023-980.pdf
Size:
1.33 MB
Format:
Adobe Portable Document Format